Track the Thyrocare Tech stock price and the full directors' dealings record of the company, a listed equity based in India. Shares are quoted on the IN market, under the authority of SEBI (PIT + SAST). Operating in the Technology sector, Thyrocare Tech has recorded 12 reports. Market capitalisation: €94.2bn. The latest transaction was filed on 9 September 2026 (Acquisition). Among the most active insiders: Docon Technologies Private Limited. Every trade is free.
12
Insider Decl.
n/a
Thresholds
n/a
2 ops.
Buy Volume
€89m
6 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Thyrocare Tech Strong Buy (bullish), based on 5 analysts. Average price target: ₹671.00.
36Σ signal
Buys n/a€89m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 8,987 of 29,063 companies
61.1
score / 100
Value
34
Quality
88
FCF yld2.0%
Earn yld1.7%
EV/EBITDA34.5x
ROE29%
Gross mgn73%
Net mgn20%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
200 shares@ ₹471.600.0001% mcap100.0% of flowEquity SharesMarket SaleSEBI:e91e5a707bf02cd67d9702f252ff555af3177636
12 of 12 declarations
Acerca de Thyrocare Tech
Thyrocare Tech es una empresa especializada en servicios de diagnóstico médico y pruebas de laboratorio. Opera principalmente en el mercado indio y ofrece una amplia gama de pruebas de salud.